Healthcare and life sciences: navigating a hard Brexit scenario
In this session, we discuss the challenges that still need to be addressed by the healthcare and life science industry as a hard Brexit looks more likely.
We welcome Sandra Humphrey, Senior Legal Counsel at GlaxoSmithKline plc, who gives us a glimpse of GSK’s Brexit journey.
Also our international team of experts explore regulatory, IP, competition, tax and corporate issues to help you navigate these uncertain times.






.jpg?crop=300,495&format=webply&auto=webp)




